On Monday, Codexis Inc (NASDAQ: CDXS) opened lower -3.47% from the last session, before settling in for the closing price of $2.59. Price fluctuations for CDXS have ranged from $1.90 to $6.08 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -33.31%. Company’s average yearly earnings per share was noted 26.16% at the time writing. With a float of $87.50 million, this company’s outstanding shares have now reached $90.25 million.
The extent of productivity of a business whose workforce counts for 188 workers is very important to gauge.
Codexis Inc (CDXS) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Codexis Inc is 3.07%, while institutional ownership is 79.43%. The most recent insider transaction that took place on Jul 31 ’25, was worth 225,710. In this transaction 10% Owner of this company bought 84,220 shares at a rate of $2.68, taking the stock ownership to the 12,544,220 shares. Before that another transaction happened on Aug 04 ’25, when Company’s 10% Owner bought 780 for $2.83, making the entire transaction worth $2,211. This insider now owns 12,545,000 shares in total.
Codexis Inc (CDXS) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.29 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.21) by -0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 27.92% during the next five years compared to -33.31% drop over the previous five years of trading.
Codexis Inc (NASDAQ: CDXS) Trading Performance Indicators
Check out the current performance indicators for Codexis Inc (CDXS). In the past quarter, the stock posted a quick ratio of 5.70. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.82, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.57 in one year’s time.